AI Stock Finder
Loading...
Skip to main content
Model output · Signal date Oct. 14, 2026

Daily SignalsNeutral

2482 companies scored · 2026-10-14 run in progress: 3971 of ~5379 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D

Signal date 2026-10-14 Cut-offs from the 2026-10-13 run
Companies scored 2482 IC ≥ 0 · market cap ≥ $100M
Median forecast +3.08% Total · 90D
Long–short spread +5.02% Strong Buy minus Strong Sell, mean
Median IC 0.29 Spearman · 90D
Rating changes ▲ 46 ▼ 45 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · Neutral

64 companies

Sorted by 90D forecast ↓

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
51 PAHCPHIBRO ANIMAL HEALTH CORP Life Sciences 0.47 $1.5B Neutral +0.76% +2.51% ·
52 VTRSViatris Inc Life Sciences 0.36 $19.8B Neutral +0.81% +2.49% ·
53 PEPGPepGen Inc. Life Sciences 0.38 $173M Neutral +1.10% +2.48% ·
54 AMRNAMARIN CORP PLC\UK Life Sciences 0.14 $4.9B Neutral +1.09% +2.46% ·
55 MSLESatellos Bioscience Inc. Life Sciences 0.37 $109M Neutral +0.95% +2.42% ·
56 NWBONORTHWEST BIOTHERAPEUTICS INC Life Sciences 0.01 $277M Neutral +0.78% +2.37% ·
57 AMPHAmphastar Pharmaceuticals, Inc. Life Sciences 0.47 $1.1B Neutral +0.68% +2.35% ·
58 GALTGALECTIN THERAPEUTICS INC Life Sciences 0.08 $372M Neutral +1.06% +2.33% ·
59 LABSTANDARD BIOTOOLS INC. Life Sciences 0.27 $259M Neutral +0.85% +2.29% ·
60 AGIOAGIOS PHARMACEUTICALS, INC. Life Sciences 0.02 $1.8B Neutral +0.65% +2.28% ·
61 MOLNMOLECULAR PARTNERS AG Life Sciences 0.03 $148M Neutral +0.62% +2.27% ·
62 ZLABZai Lab Ltd Life Sciences 0.43 $25.9B Neutral +1.31% +2.18% ·
63 CRMDCorMedix Inc. Life Sciences 0.43 $576M Neutral +0.76% +2.16% ▲ 1
64 LFCRLIFECORE BIOMEDICAL, INC. \DE\ Life Sciences 0.04 $243M Neutral +0.93% +2.15% ·
51–64 of 64 Previous Next
Since the previous run

Rating changes

▲ 46▼ 45
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.